Review



fibroblast growth factor 2  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    R&D Systems fibroblast growth factor 2
    Fibroblast Growth Factor 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fibroblast growth factor 2/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    fibroblast growth factor 2 - by Bioz Stars, 2026-04
    96/100 stars

    Images



    Similar Products

    basic fibroblast growth factor bfgf  (MedChemExpress)
    95
    MedChemExpress basic fibroblast growth factor bfgf
    Basic Fibroblast Growth Factor Bfgf, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/basic fibroblast growth factor bfgf/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    basic fibroblast growth factor bfgf - by Bioz Stars, 2026-04
    95/100 stars
    		  Buy from Supplier
    fibroblast growth factor 2  (R&D Systems)
    96
    R&D Systems fibroblast growth factor 2
    Fibroblast Growth Factor 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fibroblast growth factor 2/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    fibroblast growth factor 2 - by Bioz Stars, 2026-04
    96/100 stars
    		  Buy from Supplier
    fibroblast growth factor fgf  (R&D Systems)
    96
    R&D Systems fibroblast growth factor fgf
    Fibroblast Growth Factor Fgf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fibroblast growth factor fgf/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    fibroblast growth factor fgf - by Bioz Stars, 2026-04
    96/100 stars
    		  Buy from Supplier
    human fibroblast growth factor protein  (MedChemExpress)
    94
    MedChemExpress human fibroblast growth factor protein
    Human Fibroblast Growth Factor Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human fibroblast growth factor protein/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    human fibroblast growth factor protein - by Bioz Stars, 2026-04
    94/100 stars
    		  Buy from Supplier
    basic fibroblast growth factor  (R&D Systems)
    96
    R&D Systems basic fibroblast growth factor
    Basic Fibroblast Growth Factor, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/basic fibroblast growth factor/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    basic fibroblast growth factor - by Bioz Stars, 2026-04
    96/100 stars
    		  Buy from Supplier
    bfgf  (Elabscience Biotechnology)
    94
    Elabscience Biotechnology bfgf
    Arecoline-induced fibrosis in hOMF cells. (A) Experimental design flowchart; (B) Effects of different doses of arecoline on hOMF cell viability at 24h ( x ¯ ±s, n = 3); (C) Effects of different doses of arecoline on hOMF cell viability at 48h ( x ¯ ±s, n = 3); (D) Effects of different doses of arecoline on hOMF cell viability at 72h ( x ¯ ±s, n = 3); (E) Immunofluorescence staining of α-SMA expression in hOMF cells treated with arecoline (n = 3); (200x); (F) Immunofluorescence staining of Col1a1 expression in hOMF cells treated with arecoline (n = 3); (200x); (G) Quantitative analysis of α-SMA fluorescence intensity ( x ¯ ± s , n = 3); (H) Quantitative analysis of Col1a1 fluorescence intensity ( x ¯ ±s, n = 3). (I) Protein expression levels of <t>bFGF</t> ( x ¯ ±s, n = 3); (J) Protein expression levels <t>of</t> <t>TGF-β1</t> ( x ¯ ±s, n = 3); (K) Relative mRNA expression levels of YAP ( x ¯ ±s, n = 3); (L) Relative mRNA expression levels of TAZ ( x ¯ ±s, n = 3). Compared with the Control group, * P < 0.05, ** P < 0.01.
    Bfgf, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bfgf/product/Elabscience Biotechnology
    Average 94 stars, based on 1 article reviews
    bfgf - by Bioz Stars, 2026-04
    94/100 stars
    		  Buy from Supplier
    basic fibroblast growth factor bfgf  (R&D Systems)
    96
    R&D Systems basic fibroblast growth factor bfgf
    Arecoline-induced fibrosis in hOMF cells. (A) Experimental design flowchart; (B) Effects of different doses of arecoline on hOMF cell viability at 24h ( x ¯ ±s, n = 3); (C) Effects of different doses of arecoline on hOMF cell viability at 48h ( x ¯ ±s, n = 3); (D) Effects of different doses of arecoline on hOMF cell viability at 72h ( x ¯ ±s, n = 3); (E) Immunofluorescence staining of α-SMA expression in hOMF cells treated with arecoline (n = 3); (200x); (F) Immunofluorescence staining of Col1a1 expression in hOMF cells treated with arecoline (n = 3); (200x); (G) Quantitative analysis of α-SMA fluorescence intensity ( x ¯ ± s , n = 3); (H) Quantitative analysis of Col1a1 fluorescence intensity ( x ¯ ±s, n = 3). (I) Protein expression levels of <t>bFGF</t> ( x ¯ ±s, n = 3); (J) Protein expression levels <t>of</t> <t>TGF-β1</t> ( x ¯ ±s, n = 3); (K) Relative mRNA expression levels of YAP ( x ¯ ±s, n = 3); (L) Relative mRNA expression levels of TAZ ( x ¯ ±s, n = 3). Compared with the Control group, * P < 0.05, ** P < 0.01.
    Basic Fibroblast Growth Factor Bfgf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/basic fibroblast growth factor bfgf/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    basic fibroblast growth factor bfgf - by Bioz Stars, 2026-04
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    Arecoline-induced fibrosis in hOMF cells. (A) Experimental design flowchart; (B) Effects of different doses of arecoline on hOMF cell viability at 24h ( x ¯ ±s, n = 3); (C) Effects of different doses of arecoline on hOMF cell viability at 48h ( x ¯ ±s, n = 3); (D) Effects of different doses of arecoline on hOMF cell viability at 72h ( x ¯ ±s, n = 3); (E) Immunofluorescence staining of α-SMA expression in hOMF cells treated with arecoline (n = 3); (200x); (F) Immunofluorescence staining of Col1a1 expression in hOMF cells treated with arecoline (n = 3); (200x); (G) Quantitative analysis of α-SMA fluorescence intensity ( x ¯ ± s , n = 3); (H) Quantitative analysis of Col1a1 fluorescence intensity ( x ¯ ±s, n = 3). (I) Protein expression levels of bFGF ( x ¯ ±s, n = 3); (J) Protein expression levels of TGF-β1 ( x ¯ ±s, n = 3); (K) Relative mRNA expression levels of YAP ( x ¯ ±s, n = 3); (L) Relative mRNA expression levels of TAZ ( x ¯ ±s, n = 3). Compared with the Control group, * P < 0.05, ** P < 0.01.

    Journal: Frontiers in Physiology

    Article Title: Uncovering the mechanism of arecoline’s effect on oral submucous fibrosis: integrating transcriptomics and in vitro and in vivo experiments

    doi: 10.3389/fphys.2026.1768602

    Figure Lengend Snippet: Arecoline-induced fibrosis in hOMF cells. (A) Experimental design flowchart; (B) Effects of different doses of arecoline on hOMF cell viability at 24h ( x ¯ ±s, n = 3); (C) Effects of different doses of arecoline on hOMF cell viability at 48h ( x ¯ ±s, n = 3); (D) Effects of different doses of arecoline on hOMF cell viability at 72h ( x ¯ ±s, n = 3); (E) Immunofluorescence staining of α-SMA expression in hOMF cells treated with arecoline (n = 3); (200x); (F) Immunofluorescence staining of Col1a1 expression in hOMF cells treated with arecoline (n = 3); (200x); (G) Quantitative analysis of α-SMA fluorescence intensity ( x ¯ ± s , n = 3); (H) Quantitative analysis of Col1a1 fluorescence intensity ( x ¯ ±s, n = 3). (I) Protein expression levels of bFGF ( x ¯ ±s, n = 3); (J) Protein expression levels of TGF-β1 ( x ¯ ±s, n = 3); (K) Relative mRNA expression levels of YAP ( x ¯ ±s, n = 3); (L) Relative mRNA expression levels of TAZ ( x ¯ ±s, n = 3). Compared with the Control group, * P < 0.05, ** P < 0.01.

    Article Snippet: Primers were designed by Wuhan Kingwell Biotechnology Co., Ltd. TGF-β (E-EL-0162) and bFGF (E-EL-H6042) ELISA kits, as well as the Enhanced Cell Counting Kit 8 (WST-8/CCK8) (E-CK-A362), were purchased from Elabscience Biotechnology (Wuhan, China).

    Techniques: Immunofluorescence, Staining, Expressing, Fluorescence, Control